Amar Murugan is EVP, Chief Legal Officer of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 26,827 shares of ATRA, which is worth approximately $327,289. The most recent transaction as insider was on Aug 16, 2024, when has been sold 1,158 shares (Common Stock) at a price of $6.63 per share, resulting in proceeds of $7,677. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.8K
0% 3M change
89.56% 12M change
Total Value Held $327,289

Amar Murugan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 16 2024
SELL
Open market or private sale
$7,677 $6.63 p/Share
1,158 Reduced 4.14%
26,827 Common Stock
May 16 2024
SELL
Open market or private sale
$20,088 $0.62 p/Share
32,401 Reduced 4.45%
695,120 Common Stock
Mar 04 2024
SELL
Open market or private sale
$7,231 $0.72 p/Share
10,044 Reduced 1.36%
727,521 Common Stock
Jan 08 2024
BUY
Grant, award, or other acquisition
-
475,000 Added 39.17%
737,565 Common Stock
Nov 16 2023
SELL
Open market or private sale
$3,239 $0.39 p/Share
8,307 Reduced 3.13%
257,084 Common Stock
Aug 16 2023
SELL
Open market or private sale
$14,308 $1.65 p/Share
8,672 Reduced 3.16%
265,391 Common Stock
May 16 2023
SELL
Open market or private sale
$17,113 $2.04 p/Share
8,389 Reduced 3.0%
270,945 Common Stock
Mar 02 2023
SELL
Open market or private sale
$15,322 $3.63 p/Share
4,221 Reduced 1.49%
279,334 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
155,375 Added 35.4%
283,555 Common Stock
Nov 16 2022
SELL
Open market or private sale
$16,217 $4.49 p/Share
3,612 Reduced 2.75%
127,586 Common Stock
Aug 16 2022
SELL
Open market or private sale
$17,287 $5.04 p/Share
3,430 Reduced 2.55%
131,198 Common Stock
May 17 2022
SELL
Open market or private sale
$17,146 $5.32 p/Share
3,223 Reduced 2.35%
133,735 Common Stock
Mar 01 2022
SELL
Open market or private sale
$25,409 $9.86 p/Share
2,577 Reduced 1.85%
136,958 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
51,814 Added 27.08%
139,535 Common Stock
Nov 16 2021
SELL
Open market or private sale
$36,363 $17.12 p/Share
2,124 Reduced 2.37%
87,540 Common Stock
Aug 17 2021
SELL
Open market or private sale
$26,062 $12.53 p/Share
2,080 Reduced 2.27%
89,664 Common Stock
May 18 2021
SELL
Open market or private sale
$82,659 $14.55 p/Share
5,681 Reduced 5.83%
91,744 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
41,756 Added 30.0%
97,425 Common Stock

Also insider at

SLRN
ACELYRIN, Inc.
AM

Amar Murugan

EVP, Chief Legal Officer
South San Francisco, CA

Track Institutional and Insider Activities on ATRA

Follow Atara Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

News

Receive news related to Atara Biotherapeutics, Inc.

Track Activities on ATRA